SCORR Marketing and Applied Clinical Trials Recently Completed a Survey to Evaluate the Use of mHealth Technologies in Clinical Trials

The mobility of clinical trial data capture, monitoring and analysis technology is opening new doors for researchers, and the industry is moving fast to adopt and improve the use of mHealth. This report provides you information on how the industry is using mHealth technologies as well as what the industry sees as the objectives and challenges behind mHealth.

In the survey, information was gathered on:

- The biggest benefits of mHealth technologies in clinical trials

- The biggest challenges mHealth poses

- What factors are making it difficult for companies to implement mHealth

- Therapeutic areas where mHealth is most useful

- What companies want to achieve with mHealth technologies


Download your copy


 

Brand of the Year
Pharm Exec selects the one brand with staying power in an era of mounting pressure to demonstrate real clinical differentiation. Editor-in-Chief William Looney profiles the brand’s journey from concept to market and the developer that has helped transform a once hard-to-treat disease.

Multi-Ethnic Marketing
Pharmaceutical companies today are increasingly required to pitch their products to a highly diverse customer base. While the concept isn’t new, the tactics used to engage these varied audiences must evolve. This article explores the key strategies pharma organizations should adopt across their commercial approaches in the multi-ethnic market.

“Reddy" to Rise
Pharm Exec sits down with Dr. Bandi Parthasaradhi Reddy, chairman and managing director of Indian API manufacturer Hetero. The company, now the largest privately held drugmaker in India, has grown impressively since its founding in 1993. The profile will delve into Hetero's aspirations of becoming a global powerhouse for pharmaceutical manufacturing.

Value for Money
Pharm Exec talks to experts in the field of market access on strategies geared to better engage with payers and governments in meeting that changing dynamic called "value for money."